Ginkgo Bioworks
Total Investment:
$1,069,120,000

CATEGORY Microbial Engineering
FOUNDED 2008
HQ Boston, MA

THE BASICS

Ginkgo Bioworks operates within four foundries, which are essentially large automated laboratories, where scientists program cells to engineer organisms. Ginkgo works with partners to develop and license molecules for their partners to commercialize and distribute. In more recent years, Ginkgo has been shifting this model to develop their own subsidiary brands to bring products to market including Motif Ingredients & Joyn Bio (neither company has any products to market yet). Ginkgo’s main value proposition is the company’s automated throughput screening technology that tests thousands of engineered yeast and bacteria to generate new molecules. This iterative process is designed to generate a proprietary set of yeast cells that are fit to replicate a molecule of value such as cannabinoids or milk proteins.

GO DEEPER
CBT INSIGHTS
INVESTMENTS
×
It's free to read exclusive
CBT content
To keep viewing profiles and access exclusive data, register for a free Cell Based Tech account.

>To login, please enter your email address

Just A Few More Details
keyboard_arrow_down
  • Find investment opportunity
  • Find investors
  • Market analysis/research
  • Other
keyboard_arrow_down
  • Investment/Finance
  • Business Development
  • Engineering/Scientist
  • IT
  • Marketing/Advertising
  • Sales
  • Other